Opzelura Europska Unija - hrvatski - EMA (European Medicines Agency)

opzelura

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - ostali dermatološki pripravci - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Apoquel Europska Unija - hrvatski - EMA (European Medicines Agency)

apoquel

zoetis belgium sa - oclacitinib maleata - agenti za dermatitis, isključujući kortikosteroide - psi - - treatment of pruritus associated with allergic dermatitis in dogs. - treatment of clinical manifestations of atopic dermatitis in dogs.

Cytopoint Europska Unija - hrvatski - EMA (European Medicines Agency)

cytopoint

zoetis belgium sa - lokivetmab - ostali dermatološki preparati, sredstva za dermatitis, isključujući kortikosteroide - psi - liječenje kliničkih manifestacija atopičkog dermatitisa kod pasa.

Protopic Europska Unija - hrvatski - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrolimus - dermatitis, atopic - ostali dermatološki pripravci - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. javlja četiri ili više puta godišnje), koji su imali početni odgovor za najviše šest tjedana terapije, dva puta dnevno masti tacrolimus (mjesta očistili, gotovo izbrisani ili slabo utječe).

Dermitopic 0,1 % mast Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dermitopic 0,1 % mast

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - takrolimus hidrat - mast - 0,1% - urbroj: 1 g masti sadrži takrolimus hidrat koji odgovara 1,0 mg takrolimusa

Elidel 10 mg/g krema Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

elidel 10 mg/g krema

viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - pimekrolimus - krema - 10 mg/g - urbroj: jedan gram kreme sadrži 10 mg pimekrolimusa

ELIDEL 10 mg/1 g krema Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

elidel 10 mg/1 g krema

viatris bh d.o.o. - pimekrolimus - krema - 10 mg/1 g - 1 g krema sadrži: 10 mg pimekrolimus

Staquis Europska Unija - hrvatski - EMA (European Medicines Agency)

staquis

pfizer europe ma eeig  - crisaborole - dermatitis, atopic - ostali dermatološki pripravci - staquis naznačeno za liječenje blage do umjerene atopijski dermatitis u odraslih i pedijatrijska bolesnika od 2-x godina s ≤ 40% površine tijela (bsa) utjecaj.

Dermitopic 0,03% mast Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dermitopic 0,03% mast

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - takrolimus hidrat - mast - urbroj: 1 gram masti sadrži 0,3 mg takrolimusa u obliku hidrata

Ebglyss Europska Unija - hrvatski - EMA (European Medicines Agency)

ebglyss

almirall, s.a. - lebrikizumab - dermatitis, atopic - ostali dermatološki pripravci - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.